Skip to main content

Table 2 The baseline characteristics of the groups with and without diabetes

From: Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus

 

Diabetic (n = 1163)

Non-diabetic (n = 2478)

p value for trend

Age, years

62.10 (27–92)

61.10 (28–95)

0.019

Male, n%

809 (69.56)

1823 (73.57)

0.017

BMI(kg/m2)

26.06 ± 3.40

25.45 ± 3.56

0.000

Risk factors for atherosclerosis

   

 Current smokers, n (%)

494 (42.48)

1174 (47.38)

0.007

 Hypertension, n (%)

839 (72.14)

1531 (61.78)

0.000

 Hyperlipidemia, n (%)

342 (29.41)

778 (31.40)

0.234

Cardiac history

   

 Previous MI, n (%)

81 (6.94)

173 (6.98)

0.288

 Previous PCI/CABG, n (%)

95 (8.17)

204 (8.23)

0.312

Laboratory data

   

 TC (mmol/L)

3.96 ± 1.06

4.07 ± 1.10

0.004

 HDL-C (mmol/L)

1.05 ± 0.87

1.09 ± 0.58

0.193

 LDL-C (mmol/L)

2.32 ± 0.85

2.44 ± 0.94

0.000

 TG (mmol/L)

1.75 ± 1.32

1.57 ± 1.15

0.000

 sST2

19.98 ± 13.97

18.43 ± 13.73

0.000

 Aspirin, n (%)

1085 (93.29)

2330 (94.03)

0.591

 ACEI, n (%)

537 (46.17)

966 (38.98)

0.000

 β-blocker, n (%)

632 (54.34)

1189 (47.98)

0.039

 Statins, n (%)

1097 (94.33)

2345 (94.63)

0.918

CAD classification

   

 SAP

285 (24.51)

614 (24.78)

0.065

 ACS

954 (82.03)

1788 (72.15)

0.000